drugset

drugset / Trial / NCT00191087

Duloxetine in the Treatment of Stress Urinary Incontinence.

NCT00191087 ↗

Phase 3 Completed 458 enrolled Eli Lilly and Company Boehringer Ingelheim · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.

Timeline

Start: 2001-04
Primary completion: —
Completion: 2006-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Duloxetine	Small molecule	—	—

Indications